| __timestamp | Arrowhead Pharmaceuticals, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 56292000 |
| Thursday, January 1, 2015 | 57410147 | 74277000 |
| Friday, January 1, 2016 | 41454452 | 122721000 |
| Sunday, January 1, 2017 | 31690298 | 109749000 |
| Monday, January 1, 2018 | 52968505 | 145283000 |
| Tuesday, January 1, 2019 | 81048686 | 131711000 |
| Wednesday, January 1, 2020 | 128874979 | 181157000 |
| Friday, January 1, 2021 | 206342000 | 272744000 |
| Saturday, January 1, 2022 | 297307000 | 397518000 |
| Sunday, January 1, 2023 | 353188000 | 571011000 |
| Monday, January 1, 2024 | 505870000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Insmed Incorporated and Arrowhead Pharmaceuticals, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Insmed's R&D expenses surged by over 900%, peaking at approximately $571 million in 2023. This growth underscores Insmed's aggressive pursuit of new therapies. Meanwhile, Arrowhead Pharmaceuticals also increased its R&D spending by nearly 1500%, reaching around $506 million in 2024. This remarkable rise highlights Arrowhead's strategic focus on expanding its research capabilities.
While Insmed's data for 2024 is missing, the upward trend in both companies' R&D investments suggests a promising future for innovation in the biotech sector.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Gilead Sciences, Inc. vs Insmed Incorporated: Strategic Focus on R&D Spending
R&D Spending Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.